COPART vs FATE
COPART (COPART) versus Fate Therapeutics Inc (FATE) — a side-by-side from cached financials, not a winner call.
COPART (COPART) common stock.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
COPART does not have a complete income-statement cache yet.
Latest reported FATE revenue for 2026-06-30 was $3.4M. Net income was -$61.4M. FATE currently screens at market cap $331.0M.
FATE currently screens at market cap $331.0M.
Not investment advice. Open the COPART and FATE stock pages for the full models.
Not investment advice.